Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study
Authors:
- Vicky GohVGVicky Goh
- Jessica MilnerJMJessica Milner
- Michael R StratfordMSMichael R Stratford
- Lisa K FolkesLFLisa K Folkes
- Gillian M TozerGTGillian M Tozer
- Michele I SaundersMSMichele I Saunders
- Peter J HoskinPHPeter J Hoskin
- 1 February 2007
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 8 (2) , 111-118
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The role of nitric oxide in tumour progressionNature Reviews Cancer, 2006
- Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in miceCancer Cell, 2003
- Role of nitric oxide in carcinogenesis and tumour progressionThe Lancet Oncology, 2001
- Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeabilityProceedings of the National Academy of Sciences, 2001
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.Journal of Clinical Investigation, 1998
- Selective expression of inducible nitric oxide synthase in human prostate carcinomaCancer, 1998
- Role of Nitric Oxide in Angiogenesis and Tumor Progression in Head and Neck CancerJNCI: Journal of the National Cancer Institute, 1998
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997
- Nitric Oxide Synthase Activity in Human Lung CancerJapanese Journal of Cancer Research, 1997
- Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.Journal of Clinical Investigation, 1997